Jul 13,2016

Senseonics takes out $30m term loan

Senseonics (NYSE:SENS) said yesterday that it took out a term loan worth $30 million from Oxford Finance and Silicon Valley Bank, augmenting the $45 million it raised in an initial public offering in March.

FUNDING POST-IPO DEBT
View Analyst & Ambassador Comments
Go to original news
Jul 29,2016

Artificial Pancreas Is First To Raise $1 Million Under New Crowdfunding Rules

Beta Bionics, company creating an “artificial pancreas” for diabetics, this week became the first startup to raise $1 million using new type of online stock sale open to the public at large. The startup created by Boston University biomedical engineer Ed Damiano, hit the benchmark Wednesday night after 775 members of the public put up an average of $1,300 each to back its idea for a new kind of pacemaker for diabetics.

FUNDING EQUITY CROWDFUNDING
View Analyst & Ambassador Comments
Go to original news
Sep 01,2016

MyWay Digital Health Receives £900K Grant from SBRI Healthcare

MyWay Diabetes is granted the prize of £899,792 from the SBRI Healthcare.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Oct 21,2016

Green light for intelligent diabetes app Hedia

Hedia has landed its first investment of half a million kroner, which over the next few months will turn the startup's idea into a fully functional product. The investment is a so-called Discovery loan from PSI/SEED, which is a strategic collaboration between the innovation environment Pre-Seed Innovation and SEED Capital .

FUNDING CONVERTIBLE NOTE
View Analyst & Ambassador Comments
Go to original news
Dec 12,2016

MicroTech Completes B Round For Diabetes Devices; Qiming Leads

Qiming Venture Partners led a Series B funding in MicroTech Medical, a Hangzhou diabetes medical device company. The size of the funding round was not disclosed.

FUNDING SERIES B
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Samsung Ventures Invests in Noom, Inc. to Change Behaviors That Cause the Most Pressing Chronic Conditions

Noom, Inc., the world's leading behavior change company, today announced an investment from Samsung Ventures. Noom's platform combines human coaching and artificial intelligence to deliver successful, scalable behavior change programs that prevent and manage chronic conditions.

FUNDING SERIES C
View Analyst & Ambassador Comments
Go to original news
Dec 20,2016

Indigo Announces Successful Series A Financing Round

Indigo Diabetes, a spin-off from Ghent University and imec, today announces the successful closure of a 7 million Euros series-A financing round. The funding is provided by an international investment syndicate led by Thuja Capital Healthcare Fund II and PMV, and includes Sensinnovat, Parana Management Corp, Qbic Arkiv Fund, Fidimec, SOFI, Manuardeo and Capricorn ICT Arkiv as co-investors. This financing success will fuel the company’s development towards measuring and managing blood glucose levels without the need for finger pricks.

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Jan 01,2017

Affordable Point-of-Care Test For Multiple Diseases Being Developed by 1Drop

1Drop — with offices in Boston and in Neuchatel, Switzerland — received a $140,000 grant from the Consortia for Improving Medicine with Innovation & Technology (CIMIT) in 2017 to continue funding the firm's collaboration with Massachusetts General Hospital.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Jan 12,2017

Glucose Monitor DarioHealth Raises $5.1M

Israeli digital health and mobile health solutions developer DarioHealth Corp. (formerly Labstyle Innovations) has raised $5.1 million in a private placement. DarioHealth closed on $3.1 million of the transaction while $2 million more of gross proceeds are subject to shareholder approval per Nasdaq rules. The deal was led by OurCrowd Qure, a dedicated digital health fund that invested $2.5 million of the $5.1 million.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Feb 01,2017

Novo Nordisk Partners with Beta Bionics and Invests $5 Million

Beta Bionics shared exclusive breaking news with diaTribe today that it has received an impressive $5 million investment from insulin maker Novo Nordisk in its newest strategic partnership. This very meaningful development will help the Boston-based “public benefit corporation” advance its fully integrated iLet Bionic Pancreas device that automates delivery of insulin and insulin and glucagon (via Dexcom CGM and a smart algorithm).

FUNDING SERIES A
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES